Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 4Endocrine 4Gastrointestinal 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 76Anemia, Refractory, with Excess of Blasts 72Myelodysplastic Syndromes 69Leukemia 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Anemia 50Leukemia, Lymphocytic, Chronic, B-Cell 44Leukemia, Myelomonocytic, Chronic 42Lymphoma, Non-Hodgkin 41Multiple Myeloma 38Hodgkin Disease 36Myeloproliferative Disorders 34Primary Myelofibrosis 33Thrombocytopenia 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Lymphoma 31Neoplasms 29Anemia, Aplastic 29Congenital Abnormalities 27Anemia, Refractory 25Lymphoma, Follicular 23Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 18Burkitt Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Chronic-Phase 17Venous Thromboembolism 16Lymphoma, Large-Cell, Immunoblastic 16Leukemia, Myeloid, Accelerated Phase 16Waldenstrom Macroglobulinemia 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Diabetes Mellitus, Type 2 × Classical hematology × Clear all
NCT05315908 2024-02-28

COVID-19 Testing in Underserved and Vulnerable Populations

University of California, San Diego

Phase NA Terminated
9,120 enrolled 8 charts
Classical hematologyOther

Anemia, Sickle Cell, Coronary Artery Disease, Diabetes Mellitus, Type 2, Heart Failure, Neoplasms, Obesity, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡